Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gero Miesenböck has won the Massry Prize 2016 for his work on optogenetics. He shares the award with Karl Deisseroth of Stanford University and Peter Hegemann of the Humboldt-Universität zu Berlin.

Gero Miesenböck has won the Massry Prize 2016 for his work on optogeneticsOptogenetics uses light-operated switches to control the electrical impulses of nerve cells. The ability to remote-control neuronal function has had a profound impact on neuroscience—it provides a direct means of probing the organisation of neural circuits and of identifying the brain processes underlying perception, action, emotion, and thought.

Established by the Meira and Shaul G. Massry Foundation, the Massry Prize has been awarded since 1996 to recognize outstanding contributions to the biomedical sciences and the advancement of health. Of the previous 40 winners of the prize, 21 have also received a Lasker Award and 12 a Nobel Prize.

This year’s Massry Prize will be presented on 22 October at Beverly Hills City Hall. The three laureates will speak about their award-winning research in companion events at the University of Southern California and the University of California, Los Angeles.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Professor Dame Frances Ashcroft to receive Vanderbilt Prize in Biomedical Science

The Vanderbilt Prize in Biomedical Science recognises women scientists with a stellar record of research accomplishments who also have made significant contributions to mentoring other women in science.

Annie Park to advance our understanding of how the brain encodes reward with new Wellcome Trust Award

Congratulations are in order for Postdoctoral Fellow Dr Annie Park who has been awarded a prestigious Wellcome Early-Career Award.

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.